• Cerecor licenses Sanford Burnham Prebys' Immune Checkpoint Program

    2 monthes ago - By San Diego Biotechnology

    Strategic alliance aims to advance therapy for auto-immune disorders Sanford Burnham Prebys today announced that Cerecor Inc., a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders, has entered into an exclusive license agreement with the Institute for...
    Read more ...